Combotope Therapeutics ApS — Credit Rating and Financial Key Figures

CVR number: 44308266
Diplomvej 381, 2800 Kongens Lyngby
olablixt@combotope.com

Income statement (kDKK)

2024
Fiscal period length12
Net sales
Gross profit-2 059.79
Employee benefit expenses- 733.67
Total depreciation-9.17
EBIT-2 802.63
Other financial income2.69
Other financial expenses-1.55
Pre-tax profit-2 801.49
Income taxes616.18
Net earnings-2 185.31

Assets (kDKK)

2024
Intangible assets total
Machinery and equipment69.43
Tangible assets total69.43
Investments total130.44
Deferred tax assets616.18
Long term receivables total616.18
Inventories total
Prepayments and accrued income26.14
Current other receivables50.50
Short term receivables total76.64
Cash and bank deposits487.97
Cash and cash equivalents487.97
Balance sheet total (assets)1 380.67

Equity and liabilities (kDKK)

2024
Share capital55.30
Share premium account3 484.70
Profit of the financial year-2 185.31
Shareholders equity total1 354.69
Non-current liabilities total
Other non-interest bearing current liabilities25.98
Current liabilities total25.98
Balance sheet total (liabilities)1 380.67
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.